A peptide inhibitor called RI-AG03 targets major aggregation “hot spots” of tau proteins, believed to be a key driver of ...

In a study led by the Johns Hopkins University School of Medicine and Tufts University School of Medicine, researchers show ...

Developed by Karuna Therapeutics, which was subsequently acquired by Bristol Myers Squibb, the drug works in an entirely ...

Mental sharpness, focus, the ability to get more done in less time; people are increasingly desperate for all of these things ...

An FDA-approved synthetic version of THC (the main ingredient in cannabis) reduces agitation in patients with Alzheimer's ...

A synthetic form of the active ingredient in cannabis helps reduce agitation in people with Alzheimer's, new research shows.

Cognitive symptoms may include fear of losing control, fear of "going crazy," frightening thoughts, poor concentration and memory ... anxiety disorder is treatable and can be successfully managed with ...

AbbVie's acquisition of Cerevel Therapeutics strengthens its neuroscience pipeline with promising candidates, making ABBV a ...

“The advice we give is, if you do drink, always have at least two days a week where you don’t drink at all, because that ...

The rate of antipsychotic drug use in nursing homes has remained stubbornly high. Experts are concerned about misuse.

Dr. Kimberly Doyle from Baylor Scott & White shares valuable tips to ward off cognitive decline and keep your mind sharp as ...

When bound to endocannabinoids, these receptors regulate appetite, pain, memory ... evidence—for the self-medication of various conditions, including pain and anxiety,” says Dr. Piomelli.